BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31374869)

  • 1. Sex Differences in Medicine Acceptability: A New Factor to Be Considered in Medicine Formulation.
    Ruiz F; Keeley A; Léglise P; Tuleu C; Lachuer C; Rwabihama JP; Bachalat N; Boulaich I; Abdallah F; Rabus M; Ribemont AC; Michelon H; Wojcicki AD; Orlu M; Vallet T; Boudy V
    Pharmaceutics; 2019 Aug; 11(8):. PubMed ID: 31374869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability of oral liquid pharmaceutical products in older adults: palatability and swallowability issues.
    Belissa E; Vallet T; Laribe-Caget S; Chevallier A; Chedhomme FX; Abdallah F; Bachalat N; Belbachir SA; Boulaich I; Bloch V; Delahaye A; Depoisson M; Wojcicki AD; Gibaud S; Grancher AS; Guinot C; Lachuer C; Lechowski L; Leglise P; Mahiou A; Meaume S; Michel C; Michelon H; Orven Y; Perquy I; Piccoli M; Rabus M; Ribemont AC; Rwabihama JP; Trouvin JH; Ruiz F; Boudy V
    BMC Geriatr; 2019 Dec; 19(1):344. PubMed ID: 31810442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicines Acceptability in Hospitalized Children: An Ongoing Need for Age-Appropriate Formulations.
    Vallet T; Elhamdaoui O; Berraho A; Cherkaoui LO; Kriouile Y; Mahraoui C; Mouane N; Pense-Lheritier AM; Ruiz F; Bensouda Y
    Pharmaceutics; 2020 Aug; 12(8):. PubMed ID: 32823568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptability in the Older Population: The Importance of an Appropriate Tablet Size.
    Vallet T; Michelon H; Orlu M; Jani Y; Leglise P; Laribe-Caget S; Piccoli M; Le Fur A; Liu F; Ruiz F; Boudy V
    Pharmaceutics; 2020 Aug; 12(8):. PubMed ID: 32784378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palatability of pediatric formulations: do rats predict aversiveness?
    Simões S; Almeida AJ; Marto J
    Drug Dev Ind Pharm; 2021 Jul; 47(7):1121-1126. PubMed ID: 34545750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability of Mebendazole Chewable Tablet in Children Aged 2 to 4 Years in Peru.
    Perez F; Vallet T; Bravo Z; Callahan K; Ruiz F
    Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability of a Sublingual Drug Formulation for Respiratory Tract Infections in Children Aged 3 to 5 Years.
    Emeryk A; Vallet T; Wawryk-Gawda E; Jędrzejewski A; Durmont F; Ruiz F
    Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33672395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palatability and Stability Studies to Optimize a Carvedilol Oral Liquid Formulation for Pediatric Use.
    Chiclana-Rodríguez B; Garcia-Montoya E; Romero-Obon M; Rouaz-El-Hajoui K; Nardi-Ricart A; Suñé-Pou M; Suñé-Negre JM; Pérez-Lozano P
    Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38258041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral dosage forms for children: acceptability and palatability].
    Kojima J
    Yakugaku Zasshi; 2015; 135(2):245-7. PubMed ID: 25747220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosage Forms Suitability in Pediatrics: Acceptability of Analgesics and Antipyretics in a German Hospital.
    Klingmann V; Vallet T; Münch J; Stegemann R; Wolters L; Bosse HM; Ruiz F
    Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35214070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensory aspects of acceptability of bitter-flavoured 7.5 mm film-coated tablets in adults, preschool and school children.
    Hofmanová JK; Mason J; Batchelor HK
    Int J Pharm; 2020 Jul; 585():119511. PubMed ID: 32522503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is rat a good model for assessment of particulate-based taste-masked formulations?
    Ali J; Chiang M; Lee JB; Voronin GO; Bennett J; Cram A; Kagan L; Garnett MC; Roberts CJ; Gershkovich P
    Eur J Pharm Biopharm; 2020 Jan; 146():1-9. PubMed ID: 31726218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring Acceptability Drivers of Oral Antibiotics in Children: Findings from an International Observational Study.
    Vallet T; Bensouda Y; Saito J; Mathiesen L; Pokharkar V; Klingmann V; Peak M; Elhamdaoui O; Yamatani A; Ivanovic I; Sajith M; Münch J; Bracken L; Duncan JC; Salunke S; Wang S; Ruiz F
    Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34684014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assessment of TRPM5-dependent oral aversiveness of pharmaceuticals using a mouse brief-access taste aversion assay.
    Devantier HR; Long DJ; Brennan FX; Carlucci SA; Hendrix C; Bryant RW; Salemme FR; Palmer RK
    Behav Pharmacol; 2008 Oct; 19(7):673-82. PubMed ID: 18797244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of oral formulation-dependent characteristics of orodispersible tablets using texture profiles and multivariate data analysis.
    Casian T; Bogdan C; Tarta D; Moldovan M; Tomuta I; Iurian S
    J Pharm Biomed Anal; 2018 Apr; 152():47-56. PubMed ID: 29414018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosage form suitability in vulnerable populations: A focus on paracetamol acceptability from infants to centenarians.
    Ruiz F; Vallet T; Dufaÿ Wojcicki A; Belissa É; Fontan JE; de Pontual L; Nathanson S; Chevallier A; Laribe-Caget S; Boudy V
    PLoS One; 2019; 14(8):e0221261. PubMed ID: 31430323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient Acceptability and Preferences for Solid Oral Dosage Form Drug Product Attributes: A Scoping Review.
    Hauber B; Hand MV; Hancock BC; Zarrella J; Harding L; Ogden-Barker M; Antipas AS; Watt SJ
    Patient Prefer Adherence; 2024; 18():1281-1297. PubMed ID: 38919378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of acceptability of oral paediatric medicines: a review.
    Mistry P; Batchelor H;
    J Pharm Pharmacol; 2017 Apr; 69(4):361-376. PubMed ID: 27524471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rats can predict aversiveness of Active Pharmaceutical Ingredients.
    Soto J; Keeley A; Keating AV; Mohamed-Ahmed AHA; Sheng Y; Winzenburg G; Turner R; Desset-Brèthes S; Orlu M; Tuleu C
    Eur J Pharm Biopharm; 2018 Dec; 133():77-84. PubMed ID: 30267837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the Acceptability, Swallowability, and Palatability of Film-Coated Mini-Tablet Formulation in Young Children: Results from an Open-Label, Single-Dose, Cross-Over Study.
    Münch J; Sessler I; Bosse HM; Wargenau M; Dreesen JD; Loforese G; Webb NJA; Sivasubramanian R; Reidemeister S; Lustenberger P; Klingmann V
    Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.